CD34 and neoplasm: To evaluate whether quantifying mtDNAc in BMMCs accurately reflects levels in the leukemic stem/progenitor cell fraction rather than a signal from the tumor microenvironment, we isolated CD34+/CD117+ cells (enriched for leukemic stem-progenitor cells, LSPCs) and measured the mtDNAc by qPCR.